Government Employees Health Association v. Actelion Pharmaceuticals Ltd. et al
Case Number:
1:18-cv-03560
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- ArentFox Schiff
- Bowman & Brooke
- Cohen Milstein
- Conti Fenn
- Cravath Swaine
- Dechert LLP
- Hagens Berman
- Jackson Lewis PC
- Law Offices of E. David Hoskins
- Lawrence Law LLC
- Orrick Herrington
- Patterson Belknap
- Paul Weiss
- Radice Law Firm
- Ross Feller Casey
- Seeger Weiss
- Taus Cebulash
- Womble Bond
Companies
Sectors & Industries:
-
March 06, 2026
Actelion Pays $65M To Settle Tracleer Antitrust Class Suit
Actelion Pharmaceuticals Ltd. agreed to pay $65 million to resolve antitrust claims from a certified class accusing it of illegally denying generics companies the samples they need to produce generic versions of its hypertension drug Tracleer, according to a brief in Maryland federal court seeking preliminary approval of the settlement.
-
September 06, 2024
Actelion Must Face Tracleer Antitrust Suit With Class Certified
A Maryland federal judge refused Friday to toss an antitrust suit accusing Actelion Pharmaceuticals of illegally denying generics companies the samples they needed to produce generic versions of its hypertension drug Tracleer, while separately certifying a class composed of "hundreds" of insurers and self-funded employers.
-
February 21, 2024
Actelion Cites FDA Safety Rules Against Tracleer Antitrust Suit
Actelion Pharmaceuticals Ltd. said federal rules controlling distribution of potentially dangerous drugs spare it from antitrust litigation over its hypertension drug Tracleer, arguing it was required to deny needed samples to would-be generic competitors until they presented the right certification of safeguards.